An international pharmaceutical company with a broad portfolio of therapies used in hospital settings faced a significant reimbursement challenge when several products commonly administered in the hospital outpatient…
Read more
A client health system came to Applied Policy when it faced an untenable choice: either turn away Medicare beneficiaries with intrahepatic cholangiocarcinoma (iCCA) or absorb the $800,000 to…
Read more
Our client, a long-established medical device supplier, has built a national reputation for leadership in integrated diabetes management. By combining technological innovation and patient-centered design, the company brings…
Read more
A physician-owned health system serving more than 1.3 million residents through general acute care services, graduate medical education, and wellness and preventative programs across 70 sub-specialties faced a…
Read more
A durable medical equipment (DME) supplier delivering insulin pumps and related supplies sought crossover claim reimbursement for Qualified Medicare Beneficiaries (QMBs) in a Northeastern state. Although the supplier…
Read more
A pharmaceutical manufacturer preparing to launch a new antibiotic in the inpatient hospital setting faced a significant reimbursement barrier. Under Medicare’s Inpatient Prospective Payment System (IPPS), hospital services…
Read more
A global pharmaceutical manufacturer turned to Applied Policy for strategic guidance as the Centers for Medicare & Medicaid Services (CMS) introduced emerging bundled payment initiatives. The client, based…
Read more
Our client is a physician-owned health system providing general acute care services, graduate medical education, and individually tailored wellness and preventive health programs across 70 subspecialties to more…
Read moreNo case studies match your filters.
